BetterLife Pharma Inc.
BETR
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -1.32M | -585.80K | -1.28M | -2.56M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -245.10K | -568.20K | -1.03M | -763.90K | 568.90K |
| Change in Net Operating Assets | 870.40K | 1.73M | 1.36M | 1.18M | 512.10K |
| Cash from Operations | -458.80K | -157.50K | -252.90K | -858.90K | -1.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 411.00K | 25.00K | 25.00K | 0.00 | 1.22M |
| Total Debt Repaid | -5.00K | -1.80K | -- | -- | -- |
| Issuance of Common Stock | 223.20K | 183.70K | 218.10K | 773.10K | 748.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 20.20K |
| Cash from Financing | 461.50K | 149.80K | 176.30K | 563.80K | 1.46M |
| Foreign Exchange rate Adjustments | 400.00 | -100.00 | 300.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.10K | -7.70K | -76.30K | -295.20K | -18.70K |